Published in Prog Neuropsychopharmacol Biol Psychiatry on July 27, 2012
Novel psychoactive substances of interest for psychiatry. World Psychiatry (2015) 1.17
Synthetic Cathinones: A New Public Health Problem. Curr Neuropharmacol (2015) 0.94
Harm reduction and knowledge exchange-a qualitative analysis of drug-related Internet discussion forums. Harm Reduct J (2014) 0.92
Synthetic cathinones and their rewarding and reinforcing effects in rodents. Adv Neurosci (Hindawi) (2014) 0.90
Educated Guesses and Other Ways to Address the Pharmacological Uncertainty of Designer Drugs: An Exploratory Study of Experimentation Through an Online Drug Forum. Contemp Drug Probl (2016) 0.84
"Chasing the high" - experiences of ethylphenidate as described on international internet forums. Subst Abuse (2015) 0.83
Synthetic cannabinoids 2015: An update for pediatricians in clinical practice. World J Clin Pediatr (2016) 0.81
Intravenous self-administration of entactogen-class stimulants in male rats. Neuropharmacology (2015) 0.80
Infodemiology and infoveillance of multiple sclerosis in Italy. Mult Scler Int (2013) 0.78
Sex Differences in Hookah-Related Images Posted on Tumblr: A Content Analysis. J Health Commun (2016) 0.76
Human Pharmacology of Mephedrone in Comparison with MDMA. Neuropsychopharmacology (2016) 0.76
Manganese-enhanced magnetic resonance imaging reveals differential long-term neuroadaptation after methamphetamine and the substituted cathinone 4-methylmethcathinone (mephedrone). Int J Neuropsychopharmacol (2014) 0.76
Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants. Front Neurosci (2016) 0.75
Detecting a signal in the noise: monitoring the global spread of novel psychoactive substances using media and other open-source information. Hum Psychopharmacol (2015) 0.75
Synthetic cannabinoids found in "spice" products alter body temperature and cardiovascular parameters in conscious male rats. Drug Alcohol Depend (2017) 0.75
Integrating Personalized Technology in Toxicology: Sensors, Smart Glass, and Social Media Applications in Toxicology Research. J Med Toxicol (2017) 0.75
Genome-wide association study of alcohol dependence. Arch Gen Psychiatry (2009) 3.08
Mephedrone, new kid for the chop? Addiction (2010) 2.01
Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues. Psychopharmacology (Berl) (2010) 1.94
Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998-2000. Br J Psychiatry (2004) 1.92
Substitution of (R,S)-methadone by (R)-methadone: Impact on QTc interval. Arch Intern Med (2010) 1.87
Statin use and risk of prostate cancer: a meta-analysis of observational studies. PLoS One (2012) 1.74
The effectiveness of a school-based substance abuse prevention program: EU-Dap cluster randomised controlled trial. Prev Med (2008) 1.64
Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS One (2013) 1.59
Risk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy. Clin Infect Dis (2013) 1.44
Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis. Drug Alcohol Depend (2002) 1.40
Characteristics of heroin addicts entering methadone maintenance treatment: quality of life and gender. Subst Use Misuse (2004) 1.39
[Pharmacological treatment of pathological gambling]. Tidsskr Nor Laegeforen (2006) 1.39
Genome-wide significant association between alcohol dependence and a variant in the ADH gene cluster. Addict Biol (2011) 1.37
3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics. J Pharmacol Exp Ther (2002) 1.32
"Legal highs" on the net-Evaluation of UK-based Websites, products and product information. Forensic Sci Int (2010) 1.27
The effectiveness of a school-based substance abuse prevention program: 18-month follow-up of the EU-Dap cluster randomized controlled trial. Drug Alcohol Depend (2010) 1.23
Human factors in clinical handover: development and testing of a 'handover performance tool' for doctors' shift handovers. Int J Qual Health Care (2012) 1.18
"Spiceophrenia": a systematic overview of "spice"-related psychopathological issues and a case report. Hum Psychopharmacol (2013) 1.18
Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment. Am J Med Genet B Neuropsychiatr Genet (2009) 1.14
Topical review on the abuse and misuse potential of tramadol and tilidine in Germany. Subst Abus (2013) 1.13
Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project. Hum Psychopharmacol (2013) 1.12
Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response. PLoS One (2011) 1.08
Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients. Drug Alcohol Depend (2008) 1.08
Escape from HLA-B*08-restricted CD8 T cells by hepatitis C virus is associated with fitness costs. J Virol (2008) 1.08
Designer drugs on the internet: a phenomenon out-of-control? the emergence of hallucinogenic drug Bromo-Dragonfly. Curr Clin Pharmacol (2011) 1.08
From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamine. CNS Neurosci Ther (2013) 1.08
e-Psychonauts: conducting research in online drug forum communities. J Ment Health (2012) 1.06
[Analysis of online reports on the potential misuse of benzidamine]. Riv Psichiatr (2013) 1.05
Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data. Psychother Psychosom (2011) 1.04
Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Subst Use Misuse (2008) 1.03
Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients. J Psychiatr Res (2010) 1.02
'Legal highs' an inappropriate term for 'Novel Psychoactive Drugs' in drug prevention and scientific debate. Int J Drug Policy (2012) 1.02
CD8+ T-cell response promotes evolution of hepatitis C virus nonstructural proteins. Gastroenterology (2011) 1.01
The effects of methadone and its role in fatalities. Hum Psychopharmacol (2004) 1.01
Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine. Hum Psychopharmacol (2012) 1.01
A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice. Br J Pharmacol (2005) 1.01
Phenazepam abuse in the UK: an emerging problem causing serious adverse health problems, including death. Hum Psychopharmacol (2012) 0.99
Assessment of the neuropeptide S system in anxiety disorders. Biol Psychiatry (2010) 0.99
Disentangling structural brain alterations associated with violent behavior from those associated with substance use disorders. Arch Gen Psychiatry (2011) 0.98
Cause and manner of death in drug-related fatality: an analysis of drug-related deaths recorded by coroners in England and Wales in 2000. Drug Alcohol Depend (2003) 0.98
Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users. J Clin Psychopharmacol (2007) 0.97
Translational characterization of [11C]GSK931145, a PET ligand for the glycine transporter type 1. Synapse (2011) 0.96
Craving in alcohol-dependent patients after detoxification is related to glutamatergic dysfunction in the nucleus accumbens and the anterior cingulate cortex. Neuropsychopharmacology (2013) 0.95
Efficacy of psychostimulant drugs for amphetamine abuse or dependence. Cochrane Database Syst Rev (2013) 0.94
Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics. J Pharmacol Exp Ther (2007) 0.94
MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers. Eur J Clin Pharmacol (2005) 0.94
Motivational structure and alcohol use of university students across four nations. J Stud Alcohol (2002) 0.94
Psychiatric, behavioural and social risk factors for HIV infection among female drug users. AIDS Behav (2011) 0.93
Degree of cross-genotype reactivity of hepatitis C virus-specific CD8+ T cells directed against NS3. Hepatology (2009) 0.93
Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. Addiction (2013) 0.92
Drugs on the web; the Psychonaut 2002 EU project. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.92
Pregabalin misuse-related issues; intake of large dosages, drug-smoking allegations, and possible association with myositis: two case reports. J Clin Psychopharmacol (2012) 0.92